Crinetics Pharmaceuticals Inc (CRNX) stock has risen 67.31% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CRNX stock a score of 76 out of a possible 100.
That rank is influenced by a long-term technical score of 100. CRNX's rank also includes a short-term technical score of 80.
Is Crinetics Pharmaceuticals Inc (CRNX) Stock a Smart Investment Tuesday?
Mentioned in this article
CRNX has an Overall Score of 76. Find out what this means to you and get the rest of the rankings on CRNX!